VERSITI BLOOD HEALTH INC: Form 990, tax year 2024
View the entire original 990 at ProPublica ↗
- Organization
- VERSITI BLOOD HEALTH INC (EIN 39-0807235)
- Tax period
- 2024-01-01 to 2024-12-31
- Filed
- 2025-11-11
- IRS object ID
- 202513159349304706
- Schema version
- 2024v5.2
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule G
- Schedule I
- Schedule J
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2025-11-11T13:48:00-06:00 | ReturnTs |
| Tax Period End | 2024-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 991856619 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | GRANT THORNTON ADVISORS LLC | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 53 STATE STREET SUITE 1600 | AddressLine1Txt |
| City | BOSTON | CityNm |
| State Abbreviation | MA | StateAbbreviationCd |
| ZIP | 02109 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2024-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 390807235 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | VERSITI WISCONSIN INC | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | VERS | BusinessNameControlTxt |
| Phone | 4149335000 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | PO BOX 2178 | AddressLine1Txt |
| City | MILWAUKEE | CityNm |
| State Abbreviation | WI | StateAbbreviationCd |
| ZIP | 532012178 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | CHRIS MISKEL | PersonNm |
| Person Title | PRESIDENT & CEO | PersonTitleTxt |
| Phone | 4149335000 | PhoneNum |
| Signature | 2025-11-11 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IRS Responsible Prty Info Curr | 0 | IRSResponsiblePrtyInfoCurrInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | ERIN COUTURE | PreparerPersonNm |
| PTIN | P01390592 | PTIN |
| Phone | 6177237900 | PhoneNum |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2024 | TaxYr |
| Build TS | 2025-03-06 01:10:19Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | CHRIS MISKEL | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | PO BOX 2178 | AddressLine1Txt |
| City | MILWAUKEE | CityNm |
| State Abbreviation | WI | StateAbbreviationCd |
| ZIP | 532012178 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $303,566,482 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.VERSITI.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1947 | FormationYr |
| Legal Domicile State | WI | LegalDomicileStateCd |
| Activity Or Mission | (SEE SCHEDULE O) | ActivityOrMissionDesc |
| Voting Members Governing Body | 18 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 17 | VotingMembersIndependentCnt |
| Total Employee | 1342 | TotalEmployeeCnt |
| Total Volunteers | 289 | TotalVolunteersCnt |
| Total Gross UBI | $4,207,653 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $6,612 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $35,533,265 | PYContributionsGrantsAmt |
| CY Contributions Grants | $47,346,648 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $195,099,800 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $228,515,997 | CYProgramServiceRevenueAmt |
| PY Investment Income | $3,894,142 | PYInvestmentIncomeAmt |
| CY Investment Income | $4,323,810 | CYInvestmentIncomeAmt |
| PY Other Revenue | $677,285 | PYOtherRevenueAmt |
| CY Other Revenue | $833,792 | CYOtherRevenueAmt |
| PY Total Revenue | $235,204,492 | PYTotalRevenueAmt |
| CY Total Revenue | $281,020,247 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $3,971,528 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $4,046,177 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $99,706,668 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $112,637,915 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $0 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $127,290,428 | PYOtherExpensesAmt |
| CY Other Expenses | $146,956,995 | CYOtherExpensesAmt |
| PY Total Expenses | $230,968,624 | PYTotalExpensesAmt |
| CY Total Expenses | $263,641,087 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $4,235,868 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $17,379,160 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $188,812,448 | TotalAssetsBOYAmt |
| Total Assets EOY | $213,041,862 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $68,196,230 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $75,346,695 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $120,616,218 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $137,695,167 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | VERSITI WISCONSIN, INC. (VERSITI) IS A BLOOD HEALTH INNOVATOR WHICH ENHANCES LIVES THROUGH DISCOVERY, DIAGNOSIS AND TREATMENT. VERSITI EXPANDS THE FRONTIERS OF PATIENT HEALTH THROUGH THE INTEGRATION OF SCIENCE, MEDICINE AND SERVICE. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | 0 | SignificantChangeInd |
| Expense | $58,410,965 | ExpenseAmt |
| Grant | $129,750 | GrantAmt |
| Revenue | $66,310,411 | RevenueAmt |
| Desc | VERSITI OPERATES THE COMPREHENSIVE CENTER FOR BLEEDING DISORDERS (CCBD) UNDER A FEDERAL SUBAWARD AGREEMENT OF THE SOCIAL SECURITY ACT, PROVIDING SPECIALIZED DIAGNOSIS, TREATMENT, AND SUPPORTIVE CARE TO PATIENTS WITH INHERITED AND ACQUIRED BLEEDING AND CLOTTING DISORDERS. AS PART OF VERSITI'S MISSION TO IMPROVE PATIENT OUTCOMES, CCBD DELIVERS COMPREHENSIVE CARE THROUGH A MULTIDISCIPLINARY TEAM OF HEMATOLOGISTS, NURSES, SOCIAL WORKERS, AND SPECIALIZED STAFF. IN 2024, CCBD PROVIDED CRITICAL SERVICES TO PATIENTS WITH BLEEDING DISORDERS AND THEIR FAMILIES, INCLUDING FOR HEMOPHILIA A AND B, VON WILLEBRAND DISEASE, AND OTHER RARE COAGULATION DISORDERS. CCBD PROVIDED 17,470 SPECIALTY PHARMACY PRODUCTS IN 2024 AND CONTINUES TO BE A FEDERALLY RECOGNIZED HEMOPHILIA TREATMENT CENTER (HTC). AS A (CONTINUED IN SCHEDULE O) COVERED ENTITY UNDER THE 340B DRUG DISCOUNT PROGRAM, VERSITI ACCESSES SPECIALTY PHARMACEUTICALS AT DISCOUNTED PRICING, PASSING SAVINGS ON TO PATIENTS AND REDUCING COSTS TO THE HEALTHCARE SYSTEM WHILE ENSURING PHARMACEUTICAL NET INCOME SUPPORTS PROGRAM ACTIVITIES INCLUDING PATIENT CARE, EDUCATION, SUPPORT SERVICES, AND APPROVED RESEARCH. VERSITI PROVIDES THESE SPECIALTY PHARMACY PRODUCTS TO HOME CARE PATIENTS AND HOSPITAL SYSTEMS, IMPROVING MEDICATION ACCESS AND ADHERENCE. THE CENTER'S COMPREHENSIVE SERVICES INCLUDE FACTOR REPLACEMENT THERAPY, PROPHYLACTIC TREATMENT PROTOCOLS, GENETIC COUNSELING, AND PATIENT EDUCATION PROGRAMS DESIGNED TO HELP INDIVIDUALS WITH BLEEDING DISORDERS LIVE FULL, ACTIVE LIVES. THROUGH SPECIALIZED EXPERTISE, FEDERAL PARTNERSHIP, AND COMPASSIONATE CARE, CCBD SERVES AS A PREMIER RESOURCE FOR BLEEDING DISORDER TREATMENT, IMPROVING OUTCOMES WHILE REDUCING HEALTHCARE COSTS FOR PATIENTS WITH THESE COMPLEX CONDITIONS. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $47,161,515 | ExpenseAmt |
| Grant | $77,971 | GrantAmt |
| Revenue | $54,769,275 | RevenueAmt |
| Desc | VERSITI WISCONSIN RECRUITS VOLUNTEER BLOOD DONORS AND COLLECTS, PROCESSES, AND DISTRIBUTES BLOOD PRODUCTS AS PART OF ITS MISSION TO PROVIDE A SAFE AND RELIABLE BLOOD SUPPLY FOR HOSPITALS AND HEALTHCARE SYSTEMS ACROSS WISCONSIN. VERSITI'S COMPREHENSIVE BLOOD INVENTORY INCLUDES RED BLOOD CELLS, PLATELETS, PLASMA, AND SPECIALIZED PRODUCTS DESIGNED TO MEET PATIENT NEEDS. IN 2024, VERSITI WISCONSIN COLLECTED TOTAL RED BLOOD CELLS AND PLATELETS OF 152,765, SERVING 62 HOSPITALS. THE ORGANIZATION HOSTED 2,808 COMMUNITY BLOOD DRIVES, ENGAGING 56,626 VOLUNTEER DONORS WHO CONTRIBUTED TO VERSITI'S LIFESAVING MISSION. (CONTINUED IN SCHEDULE O)INNOVATION AND EMERGENCY RESPONSE: DURING 2024, VERSITI WISCONSIN PARTNERED WITH MILWAUKEE COUNTY TO LAUNCH AN INNOVATIVE EMS PREHOSPITAL WHOLE BLOOD TRANSFUSION PROGRAM FOR CRITICALLY INJURED TRAUMA PATIENTS, THE FIRST SUCH PARTNERSHIP IN WISCONSIN. COMMUNITY PARTNERSHIPS: AS A VITAL PARTNER IN PUBLIC HEALTH, VERSITI WISCONSIN PARTICIPATED IN THE #KNOWSCD SICKLE CELL DISEASE AWARENESS CAMPAIGN, THE WE GIVE BLOOD DRIVE PARTNERSHIP WITH ABBOTT AND THE BIG TEN CONFERENCE DURING THE 2024 FOOTBALL SEASON, AND THE ORGANIZATION'S VERSITI ON KING COMMUNITY CENTER CONDUCTED BLOOD TYPING EVENTS FOR 140 INDIVIDUALS, IDENTIFYING 43 POTENTIAL RO DONORS TO SUPPORT PATIENTS WITH SICKLE CELL DISEASE. INFRASTRUCTURE AND OPERATIONS: VERSITI WISCONSIN OPERATES DONOR CENTERS AND MOBILE COLLECTION UNITS THROUGHOUT THE STATE. IN 2024, THE ORGANIZATION COMPLETED 4 DONOR CENTER RENOVATIONS TO IMPROVE DONOR COMFORT, ENHANCE OPERATIONAL EFFICIENCY, AND EXPAND COLLECTION CAPACITY. THROUGH DEDICATED VOLUNTEER DONORS AND STRATEGIC COMMUNITY PARTNERSHIPS, VERSITI WISCONSIN MAINTAINS A ROBUST BLOOD SUPPLY THAT ENABLES HOSPITALS TO PROVIDE CRITICAL CARE, EMERGENCY SERVICES, AND LIFESAVING TREATMENTS TO PATIENTS THROUGHOUT THE REGION. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $39,725,349 | ExpenseAmt |
| Grant | $3,812,500 | GrantAmt |
| Revenue | $0 | RevenueAmt |
| Desc | VERSITI RESEARCH ADVANCES SCIENTIFIC DISCOVERY AND PATIENT CARE THROUGH COMPREHENSIVE SUPPORT OF BLOOD-RELATED RESEARCH, EDUCATION, AND COMMUNITY ENGAGEMENT PROGRAMS. ROOTED IN ITS NONPROFIT MISSION, VERSITI ENABLES GROUNDBREAKING BLOOD RESEARCH WHILE FOSTERING THE NEXT GENERATION OF SCIENTISTS AND IMPROVING THE LIVES OF PATIENTS AFFLICTED BY BLOOD DISORDERS. IN 2024, VERSITI RESEARCHERS PUBLISHED 122 PEER-REVIEWED MANUSCRIPTS WITH 45 FEATURING VBRI FACULTY AS LEAD OR SENIOR AUTHORS, INCLUDING 5 PUBLICATIONS IN JOURNALS WITH IMPACT FACTORS EXCEEDING 30. 7 IN JOURNALS WITH IMPACT FACTORS BETWEEN 20 AND 30, AND 17 IN JOURNALS WITH IMPACT FACTORS BETWEEN 10 AND 20. VERSITI'S RESEARCH SPANS 5 MAJOR PROGRAMS: TRANSFUSION MEDICINE, VASCULAR BIOLOGY, AND CELLULAR THERAPY; THROMBOSIS AND (CONTINUED IN SCHEDULE O) HEMOSTASIS; STEM CELL BIOLOGY AND HEMATOPOIESIS; IMMUNOLOGY; AND TRANSLATIONAL HEMATOLOGY. VERSITI'S RESEARCH GRANT TEAMS PROCESSED APPROXIMATELY $41M IN NEW MULTI-YEAR GRANTS AND SUBMITTED 112 PROPOSALS TOTALING $140.13M IN 2024. VERSITI ALSO LEADS THROUGH COLLABORATIVE BLOOD SCIENCE INITIATIVES SUCH AS IN VENUS (VENOUS THROMBOEMBOLISM NETWORK US) AND REDS-IV-P (RECIPIENT EPIDEMIOLOGY AND DONOR EVALUATION STUDY), NATIONAL PROGRAMS ADVANCING THROMBOSIS TREATMENT AND BLOOD TRANSFUSION SAFETY. OPERATING IN AN 82,000 SQUARE-FOOT FACILITY, VERSITI IS HOME TO 213 RESEARCH STAFF, INCLUDING 35 INVESTIGATORS AND 22 RESEARCH SCIENTISTS, IN 2024. EDUCATIONAL INITIATIVES INCLUDE GRADUATE TRAINING, RESEARCH SYMPOSIA, AND COLLABORATIVE PARTNERSHIPS IN THE MILWAUKEE REGIONAL MEDICAL CENTER, SUCH AS THE MRMC HEMATOLOGY BIOREPOSITORY, WHICH PROVIDES ANNOTATED BIOLOGICAL SAMPLES FOR BIOMARKER DISCOVERY FOR CLINICAL PARTNERS THROUGHOUT CAMPUS. | Desc |
Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $83,154,607 | ExpenseAmt |
| Grant | $25,956 | GrantAmt |
| Revenue | $107,438,365 | RevenueAmt |
| Desc | MSI:THE VERSITI MEDICAL SERVICES INSTITUTE (MSI) ADVANCES PATIENT CARE THROUGH SPECIALIZED TREATMENT AND TRANSLATIONAL RESEARCH THAT BRIDGES CLINICAL MEDICINE AND LABORATORY SCIENCE, FOSTERING COLLABORATION BETWEEN PHYSICIAN-SCIENTISTS AND BASIC RESEARCHERS TO ACCELERATE MEDICAL DISCOVERIES. ESTABLISHED IN 2009 AND SUPPORTED BY VERSITI AND THE VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION, MSI ENABLES PHYSICIANS TO DEDICATE PROTECTED TIME TO CLINICAL RESEARCH WHILE MAINTAINING PATIENT CARE RESPONSIBILITIES. IN 2024, VERSITI PHYSICIAN-SCIENTISTS PERFORMED 3,686 THERAPEUTIC PROCEDURES. AS PART OF VERSITI'S MISSION TO ADVANCE EVIDENCE-BASED MEDICINE, MSI OPERATES THE CLINICAL TRIALS & RESEARCH OFFICE (CTRO) TO CONDUCT FDA-REGULATED CLINICAL STUDIES IN SPECIALIZED AREAS INCLUDING ALLOIMMUNE PLATELET DISORDERS, TRANSFUSION-INDUCED ACUTE LUNG INJURY, AND DRUG-INDUCED BLOOD DISORDERS. THROUGH MENTORSHIP, PROTECTED RESEARCH TIME, AND COLLABORATIVE INFRASTRUCTURE, MSI PROVIDES DEEP CLINICAL EXPERTISE AND TRANSFORMS CLINICAL QUESTIONS INTO SCIENTIFIC DISCOVERIES THAT BENEFIT PATIENTS WITH BLOOD DISORDERS NATIONWIDE.DONOR TESTING:THE VERSITI DONOR TESTING LABORATORY (DTL) PROVIDES INFECTIOUS DISEASE TESTING TO DETERMINE DONOR SUITABILITY AND PRODUCT SAFETY FOR ORGANS, TISSUES, HEMATOPOIETIC STEM CELLS, AND CORD BLOOD. THE DTL OFFERS NUCLEIC ACID TESTING, ANTIBODY SCREENING, AND CONFIRMATORY TESTING FOR MANY DIFFERENT DISEASE STATES. AS PART OF VERSITI'S MISSION TO MAINTAIN THE SAFEST POSSIBLE BLOOD SUPPLY, DONOR TESTING OPERATIONS CONDUCT MANDATORY SCREENING FOR TRANSFUSION-TRANSMISSIBLE INFECTIONS AS REQUIRED BY FDA REGULATIONS. THE DTL UTILIZES STATE-OF-THE-ART NUCLEIC ACID TESTING (NAT) TECHNOLOGY AND SEROLOGICAL METHODS TO DETECT INFECTIOUS AGENTS. VERSITI'S DTL SUPPORTS BLOOD COLLECTION ACTIVITIES ACROSS VERSITI'S ENTIRE GEOGRAPHIC FOOTPRINT WHILE MAINTAINING RIGOROUS QUALITY STANDARDS AND REGULATORY COMPLIANCE. VERSITI'S DONOR TESTING SERVICES STRENGTHEN THE NATIONAL BLOOD SUPPLY INFRASTRUCTURE. BY ENSURING COMPREHENSIVE DONOR SCREENING, VERSITI PROTECTS PATIENTS WHO DEPEND ON SAFE BLOOD TRANSFUSIONS, STRENGTHENS THE NATIONAL BLOOD SUPPLY, AND SUPPORTS THE BROADER PUBLIC HEALTH MISSION OF MAINTAINING CONFIDENCE IN A HIGH-QUALITY BLOOD SUPPLY.DIAGNOSTIC LABS:VERSITI SERVES PATIENTS, PHYSICIANS, AND HOSPITALS BY PROVIDING COMPREHENSIVE CLINICAL DIAGNOSTIC TESTING SERVICES THAT SUPPORT ACCURATE DIAGNOSIS, TREATMENT MONITORING, AND PATIENT CARE ACROSS MULTIPLE MEDICAL SPECIALTIES. AS PART OF VERSITI'S MISSION TO ADVANCE HEALTHCARE THROUGH LABORATORY EXCELLENCE, THE DIAGNOSTIC LABORATORIES DELIVER SPECIALIZED TESTING SERVICES INCLUDING HEMATOLOGY, COAGULATION, IMMUNOHEMATOLOGY, INFECTIOUS DISEASE, MOLECULAR DIAGNOSTICS, FLOW CYTOMETRY, AND REFERENCE LABORATORY SERVICES. DURING 2024, VERSITI CONDUCTED 148,545 DIAGNOSTIC TESTING SERVICES FOR HOSPITALS, PHYSICIAN OFFICES, AND REFERENCE LABORATORIES. VERSITI'S DIAGNOSTIC LABORATORIES MAINTAIN STATE-OF-THE-ART INSTRUMENTATION AND RIGOROUS QUALITY ASSURANCE PROGRAMS TO ENSURE ACCURATE, TIMELY RESULTS THAT GUIDE CLINICAL DECISION-MAKING AND IMPROVE PATIENT OUTCOMES. THE LABORATORIES PROVIDE SPECIALIZED EXPERTISE IN BLOOD-RELATED DISORDERS, OFFERING ADVANCED TESTING CAPABILITIES INCLUDING PLATELET FUNCTION ANALYSIS, COAGULATION STUDIES, RED BLOOD CELL ANTIGEN TYPING, AND COMPLEX IMMUNOHEMATOLOGY WORKUPS THAT CONFIRM AND ENSURE TRANSFUSION SAFETY. VERSITI'S DIAGNOSTIC LABORATORIES SERVE AS A VITAL HEALTHCARE INFRASTRUCTURE RESOURCE, PROVIDING 24/7 TESTING SUPPORT FOR EMERGENCY DEPARTMENTS AND CRITICAL CARE UNITS. THROUGH COMPREHENSIVE DIAGNOSTIC TESTING SERVICES, ADVANCED LABORATORY EXPERTISE, AND COMMITMENT TO QUALITY, VERSITI'S DIAGNOSTIC LABORATORIES STRENGTHEN THE HEALTHCARE SYSTEM BY ENABLING ACCURATE DIAGNOSIS AND OPTIMAL PATIENT CARE ACROSS THE STATE.ORGAN AND TISSUE:VERSITI ORGAN AND TISSUE OPERATES AS SOUTHEASTERN WISCONSIN'S FEDERALLY DESIGNATED ORGAN PROCUREMENT ORGANIZATION, COORDINATING ORGAN AND TISSUE DONATION TO SAVE AND HEAL LIVES THROUGHOUT THE STATE. ROOTED IN VERSITI'S MISSION TO ADVANCE PUBLIC HEALTH, THE ORGANIZATION FACILITATES THE GENEROUS GIFT OF DONATION BY WORKING WITH DONOR FAMILIES, HOSPITALS, AND TRANSPLANT CENTERS TO ENSURE ORGANS AND TISSUES REACH PATIENTS IN NEED. IN 2024, VERSITI ORGAN AND TISSUE COORDINATED 394 ORGAN TRANSPLANTS FROM 606 MUSCULOSKELETAL DONORS. THE ORGANIZATION PROVIDES 24/7 COORDINATION SERVICES, FAMILY SUPPORT, AND CLINICAL EXPERTISE THROUGHOUT THE DONATION PROCESS. VERSITI'S DONATION COORDINATORS AND CLINICAL STAFF WORK ALONGSIDE HOSPITAL TEAMS TO IDENTIFY POTENTIAL DONORS, SUPPORT GRIEVING FAMILIES, AND ENSURE OPTIMAL ORGAN AND TISSUE RECOVERY. THROUGH COMMUNITY EDUCATION PROGRAMS LIKE DONATE LIFE MONTH IN APRIL, VERSITI PROMOTES DONATION AWARENESS AND SUPPORTS WISCONSIN FAMILIES WHO CHOOSE THE HEALING PATH OF DONATION. BY FACILITATING ORGAN AND TISSUE DONATION, VERSITI ORGAN AND TISSUE TRANSFORMS TRAGEDY INTO HOPE, ENABLING ONE DONOR TO SAVE UP TO EIGHT LIVES THROUGH ORGAN DONATION AND HEAL DOZENS MORE THROUGH TISSUE DONATION.VCTS:VERSITI CLINICAL TRIALS SERVICES (VCTS) PROVIDES COMPREHENSIVE CLINICAL RESEARCH SERVICES TO PHARMACEUTICAL SPONSORS, BIOTECHNOLOGY COMPANIES, AND ACADEMIC INSTITUTIONS CONDUCTING CLINICAL STUDIES IN HEMATOLOGY, TRANSFUSION MEDICINE, ONCOLOGY, IMMUNOLOGY, CELL AND GENE THERAPY, AND ORPHAN AND RARE DISEASES. AS PART OF VERSITI'S MISSION TO ADVANCE MEDICAL SCIENCE, VCTS OFFERS SPECIALIZED LABORATORY SERVICES, INSTITUTIONAL REVIEW BOARD (IRB) OVERSIGHT, BIOSPECIMEN COLLECTION AND MANAGEMENT, PROJECT MANAGEMENT, AND REGULATORY SUPPORT TO ENSURE SAFE AND COMPLIANT STUDIES. VCTS LEVERAGES VERSITI'S UNIQUE EXPERTISE IN BLOOD SCIENCE AND LABORATORY DIAGNOSTICS TO SUPPORT COMPLEX TRIALS REQUIRING SPECIALIZED TESTING CAPABILITIES. THE PROGRAM MAINTAINS RIGOROUS QUALITY STANDARDS AND REGULATORY COMPLIANCE WHILE PROVIDING INNOVATIVE SOLUTIONS FOR COMPLEX CLINICAL RESEARCH CHALLENGES. THROUGH EXPERT CLINICAL RESEARCH SERVICES, VERSITI CLINICAL TRIALS ACCELERATE THE DEVELOPMENT OF NEW TREATMENTS FOR BLOOD DISORDERS AND SUPPORT THE ADVANCEMENT OF EVIDENCE-BASED MEDICINE IN HEMATOLOGY AND TRANSFUSION MEDICINE. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Prog Srvc Expense | $83,154,607 | TotalOtherProgSrvcExpenseAmt |
| Total Other Prog Srvc Grant | $25,956 | TotalOtherProgSrvcGrantAmt |
| Total Other Prog Srvc Revenue | $107,438,365 | TotalOtherProgSrvcRevenueAmt |
| Total Program Service Expenses | $228,452,436 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (1) | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Donor Rstr Or Quasi Endowments | Yes (1) | DonorRstrOrQuasiEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | Yes (1) | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (1) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (1) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | 0 | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (1) | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | 0 | ForeignActivitiesInd |
| More Than5000 K To Org | 0 | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (1) | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | Yes (1) | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With35 Ctrl Ent | 0 | BusinessRlnWith35CtrlEntInd |
| Deductible Non Cash Contri | 0 | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | Yes (1) | DisregardedEntityInd |
| Related Entity | Yes (1) | RelatedEntityInd |
| Related Organization Ctrl Ent | Yes (1) | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | Yes (1) | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 0 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Employee | 1342 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | Yes (1) | UnrelatedBusIncmOverLimitInd |
| Form990 T Filed | Yes (1) | Form990TFiledInd |
| Foreign Financial Account | 0 | ForeignFinancialAccountInd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Subj To Tax Rmnrtn Ex Prcht Pymt | Yes (1) | SubjToTaxRmnrtnExPrchtPymtInd |
| Subject To Excs Tax Net Invst Inc | 0 | SubjectToExcsTaxNetInvstIncInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 18 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 17 | IndependentVotingMemberCnt |
| Family Or Business Rln | 0 | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | Yes (1) | MembersOrStockholdersInd |
| Election Of Board Members | Yes (1) | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | Yes (1) | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (1) | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | 0 | InvestmentInJointVentureInd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| Upon Request | Yes (X) | UponRequestInd |
| Other | Yes (X) | OtherInd |
Books In Care Of Detail BooksInCareOfDetail
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | DAWN HENSE | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Phone | 4149335000 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 638 N 18TH ST | AddressLine1Txt |
| City | MILWAUKEE | CityNm |
| State Abbreviation | WI | StateAbbreviationCd |
| ZIP | 532332121 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part VII | Yes (X) | InfoInScheduleOPartVIIInd |
Form990 Part VII Section A Form990PartVIISectionAGrp (37 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|
| CHRIS MISKEL | ||||||||
| PRESIDENT & CEO | 23.00 | 32.00 | Yes (X) | Yes (X) | $713,940 | $908,656 | $57,669 | |
| FRED GEILFUSS | ||||||||
| CHAIR | 1.00 | 5.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| L ALAN WHALEY | ||||||||
| VICE CHAIR | 1.00 | 4.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| COREEN DICUS-JOHNSON JD | ||||||||
| SECRETARY | 1.00 | 4.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| RON MILLER | ||||||||
| TREASURER | 1.00 | 4.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | |
| NICHOLAS BAUER | ||||||||
| BOARD MEMBER | 1.00 | 4.00 | Yes (X) | $0 | $0 | $0 | ||
| DAVID GINSBURG MD | ||||||||
| BOARD MEMBER | 1.00 | 4.00 | Yes (X) | $0 | $0 | $0 | ||
| CECELIA GORE | ||||||||
| BOARD MEMBER | 1.00 | 4.00 | Yes (X) | $0 | $0 | $0 | ||
| GAIL HANSON | ||||||||
| BOARD MEMBER | 1.00 | 4.00 | Yes (X) | $0 | $0 | $0 | ||
| THOMAS HAUSKE JR | ||||||||
| BOARD MEMBER | 1.00 | 4.00 | Yes (X) | $0 | $0 | $0 | ||
| SHERRY HUSA | ||||||||
| BOARD MEMBER | 1.00 | 4.00 | Yes (X) | $0 | $0 | $0 | ||
| DALE KENT | ||||||||
| BOARD MEMBER | 1.00 | 4.00 | Yes (X) | $0 | $0 | $0 | ||
| ROBERT H MANEGOLD | ||||||||
| BOARD MEMBER | 1.00 | 5.00 | Yes (X) | $0 | $0 | $0 | ||
| JEFFREY S MCDONALD | ||||||||
| BOARD MEMBER | 1.00 | 4.00 | Yes (X) | $0 | $0 | $0 | ||
| MAGGEY OPLINGER | ||||||||
| BOARD MEMBER | 1.00 | 4.00 | Yes (X) | $0 | $0 | $0 | ||
| JOHN PERRAS | ||||||||
| BOARD MEMBER | 1.00 | 4.00 | Yes (X) | $0 | $0 | $0 | ||
| KATHY THORNTON-BIAS | ||||||||
| BOARD MEMBER - THRU 6/24 | 1.00 | 4.00 | Yes (X) | $0 | $0 | $0 | ||
| GREG WESLEY | ||||||||
| BOARD MEMBER | 1.00 | 4.00 | Yes (X) | $0 | $0 | $0 | ||
| PETER ZIEGLER | ||||||||
| BOARD MEMBER | 1.00 | 4.00 | Yes (X) | $0 | $0 | $0 | ||
| MATTHEW ANDERSON MD | ||||||||
| EVP & CHIEF MED. OFF. - AS OF 7/24 | 50.00 | 5.00 | Yes (X) | $471,868 | $0 | $65,850 | ||
| BRIAN BAUTISTA | ||||||||
| EVP & CHIEF OPERATING OFFICER | 24.00 | 31.00 | Yes (X) | $357,615 | $455,150 | $53,592 | ||
| LYNNE BRIGGS | ||||||||
| VP & CHIEF INFORMATION OFFICER | 24.00 | 31.00 | Yes (X) | $212,020 | $269,846 | $52,622 | ||
| BARBARA BRYANT | ||||||||
| EVP & CHIEF MED. OFF. - THRU 8/24 | 50.00 | 5.00 | Yes (X) | $447,822 | $0 | $25,848 | ||
| MICHAEL DEININGER MD | ||||||||
| EVP & CHIEF SCIENTIFIC OFFICER | 48.00 | 7.00 | Yes (X) | $637,080 | $33,530 | $39,231 | ||
| JESSICA DROUILLARD | ||||||||
| VP & CHIEF QUALITY OFFICER | 24.00 | 31.00 | Yes (X) | $121,455 | $154,582 | $18,905 | ||
| GITESH DUBAL | ||||||||
| EVP & CHIEF MKTG. OFF. - THRU 4/24 | 24.00 | 31.00 | Yes (X) | $179,108 | $227,952 | $23,781 | ||
| GRETCHEN JAMESON | ||||||||
| EVP & CHIEF MKTG. OFF. - AS OF 4/24 | 24.00 | 31.00 | Yes (X) | $96,983 | $123,432 | $15,013 | ||
| BRADLEY PIETZ | ||||||||
| EVP & CHIEF LABORATORY OFFICER | 24.00 | 31.00 | Yes (X) | $264,400 | $336,515 | $65,430 | ||
| BART REUTER | ||||||||
| EVP & GENERAL COUNSEL | 23.00 | 32.00 | Yes (X) | $379,102 | $482,498 | $66,046 | ||
| DEREK TYUS | ||||||||
| EVP & CHIEF FINANCIAL OFF. - AS 3/24 | 23.00 | 32.00 | Yes (X) | $199,013 | $253,291 | $48,353 | ||
| ANTHONY WATKINS | ||||||||
| EVP&CFO-THRU 3/24;BUS DEV-AS OF 3/24 | 23.00 | 32.00 | Yes (X) | $329,433 | $419,278 | $29,876 | ||
| JAMES WEIDNER | ||||||||
| EVP & CHIEF HR OFFICER | 24.00 | 31.00 | Yes (X) | $251,504 | $320,098 | $56,792 | ||
| KATHLEEN PUCA | ||||||||
| SR MEDICAL DIRECTOR | 55.00 | 0.00 | $442,557 | $0 | $55,500 | Yes (X) | ||
| KARIN HOFFMEISTER | ||||||||
| DEPUTY DIRECTOR VBRI | 55.00 | 0.00 | $411,046 | $0 | $49,328 | Yes (X) | ||
| CHRISTIAN J KASTRUP PHD | ||||||||
| SR INVESTIGATOR | 55.00 | 0.00 | $399,219 | $0 | $61,882 | Yes (X) | ||
| LYNN M MALEC MD | ||||||||
| SENIOR MEDICAL DIRECTOR | 55.00 | 0.00 | $384,247 | $0 | $34,890 | Yes (X) | ||
| LISA BAUMANN KREUZIGER | ||||||||
| SENIOR MEDICAL DIRECTOR | 55.00 | 0.00 | $394,936 | $0 | $40,578 | Yes (X) | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $6,693,348 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $3,984,828 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $861,186 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 211 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| MORTENSON CONSTRUCTION | |||||
| 115 S 84TH STREET STE 400 | MILWAUKEE | WI | 53214 | CONTRACTOR | $6,364,631 |
| HGA | |||||
| PO BOX 86 | MINNEAPOLIS | MN | 55486 | BUILDING DESIGN FIRM | $3,359,610 |
| MEDICAL COLLEGE OF WISCONSIN INC | |||||
| 8701 WATERTOWN PLANK RD | MILWAUKEE | WI | 53226 | RESEARCH SERVICES | $2,878,711 |
| HEALTH RESEARCH INC | |||||
| PO BOX 2966 | BUFFALO | NY | 14240 | RESEARCH SERVICES | $790,499 |
| CERNER CORPORATION | |||||
| 2800 ROCKCREEK PARKWAY | KANSAS CITY | MO | 64117 | SOFTWARE SUPPORT | $785,249 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 35 | CntrctRcvdGreaterThan100KCnt |
| Federated Campaigns | $1,170 | FederatedCampaignsAmt |
| Fundraising | $65,534 | FundraisingAmt |
| Related Organizations | $10,774,042 | RelatedOrganizationsAmt |
| Government Grants | $32,588,850 | GovernmentGrantsAmt |
| All Other Contributions | $3,917,052 | AllOtherContributionsAmt |
| Total Contributions | $47,346,648 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (5 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt | Unrelated Business RevenueUnrelatedBusinessRevenueAmt |
|---|---|---|---|---|
| PHARMACY | 621500 | $66,310,411 | $66,310,411 | |
| BLOOD SERVICES | 621991 | $54,769,275 | $54,769,275 | |
| DIAGNOSTIC LABS | 621500 | $51,114,322 | $51,114,322 | |
| ORGAN & TISSUE | 621991 | $26,103,956 | $26,103,956 | |
| BIOMATERIALS & TRIALS | 621500 | $17,724,701 | $13,745,824 | $3,978,877 |
Total Oth Program Service Rev TotalOthProgramServiceRevGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $12,493,332 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $12,493,332 | RelatedOrExemptFuncIncomeAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $228,515,997 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $3,849,579 | TotalRevenueColumnAmt |
| Exclusion | $3,849,579 | ExclusionAmt |
Gross Rents GrossRentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $4,483 | RealAmt |
Less Rental Expenses LessRentalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $12,144 | RealAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | -$7,661 | RealAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$7,661 | TotalRevenueColumnAmt |
| Exclusion | -$7,661 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $22,907,473 | SecuritiesAmt |
| Other | $63,159 | OtherAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $22,470,012 | SecuritiesAmt |
| Other | $26,389 | OtherAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $437,461 | SecuritiesAmt |
| Other | $36,770 | OtherAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $474,231 | TotalRevenueColumnAmt |
| Exclusion | $474,231 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $26,200 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $65,534 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $37,690 | FundraisingDirectExpensesAmt |
Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$11,490 | TotalRevenueColumnAmt |
| Exclusion | -$11,490 | ExclusionAmt |
Other Revenue Misc OtherRevenueMiscGrp (3 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | ExclusionExclusionAmt | Unrelated Business RevenueUnrelatedBusinessRevenueAmt |
|---|---|---|---|---|
| AFFILIATE SERVICE FEES | 900099 | $551,381 | $551,381 | |
| SHARED SERVICE FEE | 900099 | $228,776 | $228,776 | |
| ACQUIRED CASH RECEIPTS | 900099 | $66,667 | $66,667 |
Miscellaneous Revenue MiscellaneousRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $6,119 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $2,054 | RelatedOrExemptFuncIncomeAmt |
| Exclusion | $4,065 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $852,943 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $281,020,247 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $224,539,174 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $4,207,653 | UnrelatedBusinessRevenueAmt |
| Exclusion | $4,926,772 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part IX | Yes (X) | InfoInScheduleOPartIXInd |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,042,177 | TotalAmt |
| Program Services | $4,042,177 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,000 | TotalAmt |
| Program Services | $4,000 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,364,390 | TotalAmt |
| Program Services | $2,360,124 | ProgramServicesAmt |
| Management And General | $2,004,266 | ManagementAndGeneralAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $102,960 | TotalAmt |
| Management And General | $102,960 | ManagementAndGeneralAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $84,138,998 | TotalAmt |
| Program Services | $72,439,819 | ProgramServicesAmt |
| Management And General | $11,699,179 | ManagementAndGeneralAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,236,051 | TotalAmt |
| Program Services | $3,596,963 | ProgramServicesAmt |
| Management And General | $639,088 | ManagementAndGeneralAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $13,961,252 | TotalAmt |
| Program Services | $11,754,277 | ProgramServicesAmt |
| Management And General | $2,206,975 | ManagementAndGeneralAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,834,264 | TotalAmt |
| Program Services | $4,905,023 | ProgramServicesAmt |
| Management And General | $929,241 | ManagementAndGeneralAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $181,659 | TotalAmt |
| Program Services | $61,385 | ProgramServicesAmt |
| Management And General | $120,274 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $83,827 | TotalAmt |
| Program Services | $83,827 | ProgramServicesAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $66,375 | TotalAmt |
| Management And General | $66,375 | ManagementAndGeneralAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,895 | TotalAmt |
| Management And General | $5,895 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $27,035,483 | TotalAmt |
| Program Services | $26,117,290 | ProgramServicesAmt |
| Management And General | $918,193 | ManagementAndGeneralAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $876,369 | TotalAmt |
| Program Services | $475,391 | ProgramServicesAmt |
| Management And General | $400,978 | ManagementAndGeneralAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $493,537 | TotalAmt |
| Program Services | $473,267 | ProgramServicesAmt |
| Management And General | $20,270 | ManagementAndGeneralAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,661,427 | TotalAmt |
| Program Services | $2,346,892 | ProgramServicesAmt |
| Management And General | $314,535 | ManagementAndGeneralAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $15,727 | TotalAmt |
| Program Services | $15,727 | ProgramServicesAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $6,611,048 | TotalAmt |
| Program Services | $4,378,606 | ProgramServicesAmt |
| Management And General | $2,232,442 | ManagementAndGeneralAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,119,840 | TotalAmt |
| Program Services | $2,594,302 | ProgramServicesAmt |
| Management And General | $525,538 | ManagementAndGeneralAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $547,720 | TotalAmt |
| Program Services | $473,533 | ProgramServicesAmt |
| Management And General | $74,187 | ManagementAndGeneralAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $87,941 | TotalAmt |
| Program Services | $58,178 | ProgramServicesAmt |
| Management And General | $29,763 | ManagementAndGeneralAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $6,659,756 | TotalAmt |
| Program Services | $5,063,766 | ProgramServicesAmt |
| Management And General | $1,595,990 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $99,513 | TotalAmt |
| Program Services | $99,513 | ProgramServicesAmt |
Other Expenses OtherExpensesGrp (4 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt |
|---|---|---|---|
| COST OF IMPORTED PROD | $54,780,339 | $54,780,339 | |
| MEDICAL LAB SUPPLIES | $24,878,103 | $24,878,103 | |
| VERSITI SERVICES ALLOC | $14,610,805 | $4,344,313 | $10,266,492 |
| EQUIPMENT LEASE/MAINT | $3,621,223 | $3,076,794 | $544,429 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $520,408 | TotalAmt |
| Program Services | $28,827 | ProgramServicesAmt |
| Management And General | $491,581 | ManagementAndGeneralAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $263,641,087 | TotalAmt |
| Program Services | $228,452,436 | ProgramServicesAmt |
| Management And General | $35,188,651 | ManagementAndGeneralAmt |
| Fundraising | $0 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,778,539 | BOYAmt |
| EOY | $4,421,429 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,528,124 | BOYAmt |
| EOY | $12,547,670 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $38,464,994 | BOYAmt |
| EOY | $42,233,253 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $11,173,130 | BOYAmt |
| EOY | $12,095,944 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,181,467 | BOYAmt |
| EOY | $980,278 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $140,723,165 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $89,691,845 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $40,808,629 | BOYAmt |
| EOY | $51,031,320 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $44,952,503 | BOYAmt |
| EOY | $46,603,137 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $17,143,314 | BOYAmt |
| EOY | $16,217,402 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $25,991,764 | BOYAmt |
| EOY | $24,989,420 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,789,984 | BOYAmt |
| EOY | $1,922,009 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $188,812,448 | BOYAmt |
| EOY | $213,041,862 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $49,314,606 | BOYAmt |
| EOY | $56,506,442 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,602,994 | BOYAmt |
| EOY | $2,125,503 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $15,278,630 | BOYAmt |
| EOY | $16,714,750 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $68,196,230 | BOYAmt |
| EOY | $75,346,695 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows FASB117 | Yes (X) | OrganizationFollowsFASB117Ind |
No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $120,616,218 | BOYAmt |
| EOY | $125,994,810 | EOYAmt |
Donor Restriction Net Assets DonorRestrictionNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $11,700,357 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $120,616,218 | BOYAmt |
| EOY | $137,695,167 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $188,812,448 | BOYAmt |
| EOY | $213,041,862 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | $17,379,160 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $999,785 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | -$1,299,996 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consolidated Basis Fincl Stmt | Yes (X) | ConsolidatedBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (1) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (1) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $26,647,932 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $26,132,948 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $31,822,899 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $35,533,265 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $47,346,648 | CurrentTaxYearAmt |
| Total | $167,483,692 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $26,647,932 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $26,132,948 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $31,822,899 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $35,533,265 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $47,346,648 | CurrentTaxYearAmt |
| Total | $167,483,692 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $40,835,796 | SubstantialContributorsTotAmt |
| Public Support Total170 | $126,647,896 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $1,862,957 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $1,963,086 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $1,514,098 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $3,484,842 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $3,854,062 | CurrentTaxYearAmt |
| Total | $12,679,045 | TotalAmt |
Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $4,416 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $3,620 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $3,684 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $4,273 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $6,612 | CurrentTaxYearAmt |
| Total | $22,605 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $100,852 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $121,241 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $91,510 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $524,619 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $622,113 | CurrentTaxYearAmt |
| Total | $1,460,335 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $181,645,677 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $927,868,690 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.69720 | PublicSupportCY170Pct |
| Public Support PY170 | 0.67670 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Form990 Schedule A Part VI Form990ScheduleAPartVIGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: | FormAndLineReferenceDesc |
| Explanation | PATRONAGE DIVIDENDS - 2020 AMOUNT: $ 31,405. 2021 AMOUNT: $ 0. 2022 AMOUNT: $ 0. 2023 AMOUNT: $ 0. 2024 AMOUNT: $ 0. COPY FEES - 2020 AMOUNT: $ 0. 2021 AMOUNT: $ 0. 2022 AMOUNT: $ 510. 2023 AMOUNT: $ 0. 2024 AMOUNT: $ 667. MISCELLANEOUS - 2020 AMOUNT: $ 197. 2021 AMOUNT: $ 12,241. 2022 AMOUNT: $ 0. 2023 AMOUNT: $ 355. 2024 AMOUNT: $ 3,347. ACQUIRED CASH RECEIPTS - 2020 AMOUNT: $ 69,250. 2021 AMOUNT: $ 109,000. 2022 AMOUNT: $ 91,000. 2023 AMOUNT: $ 110,000. 2024 AMOUNT: $ 66,667. CREDIT CARD REBATES - 2020 AMOUNT: $ 0. 2021 AMOUNT: $ 0. 2022 AMOUNT: $ 0. 2023 AMOUNT: $ 880. 2024 AMOUNT: $ 51. AFFILIATE SERVICE FEES - 2020 AMOUNT: $ 0. 2021 AMOUNT: $ 0. 2022 AMOUNT: $ 0. 2023 AMOUNT: $ 413,384. 2024 AMOUNT: $ 551,381. | ExplanationTxt |
Schedule B IRS990ScheduleB
Contributor Information ContributorInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor | RESTRICTED | ContributorNum |
Contributor Business Name ContributorBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor US Address ContributorUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Contributions | RESTRICTED | TotalContributionsAmt |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Volunteers | 0 | VolunteersInd |
| Paid Staff Or Management | Yes (1) | PaidStaffOrManagementInd |
| Media Advertisements | 0 | MediaAdvertisementsInd |
| Mailings Members | 0 | MailingsMembersInd |
| Publications Or Broadcast | 0 | PublicationsOrBroadcastInd |
| Grants Other Organizations | 0 | GrantsOtherOrganizationsInd |
| Direct Contact Legislators | 0 | DirectContactLegislatorsInd |
| Rallies Demonstrations | 0 | RalliesDemonstrationsInd |
| Other Activities | Yes (1) | OtherActivitiesInd |
| Other Activities | $66,375 | OtherActivitiesAmt |
| Total Lobbying Expenditures | $66,375 | TotalLobbyingExpendituresAmt |
| Not Described Section501c3 | 0 | NotDescribedSection501c3Ind |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART II-B, LINE 1: | FormAndLineReferenceDesc |
| Explanation | PAID STAFF OR MANAGMENT GENERAL COUNSEL PROVIDES LOBBYING SERVICES TO THE FILING ORGANIZATION. HOWEVER, SUCH EXPENSES ARE PAID FOR BY VERSITI INC., THE FILING ORGANIZATION'S PARENT. OTHER ACTIVITIES $8,775 OF THE DUES PAID TO THE ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS AND $57,600 OF OTHER EXPENSES PAID WERE ALLOCATED TO LOBBYING ACTIVITIES. | ExplanationTxt |
Schedule D IRS990ScheduleD
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $104,985,040 | BeginningYearBalanceAmt |
| Contributions | $784,199 | ContributionsAmt |
| Investment Earnings Or Losses | $12,490,658 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $4,744,538 | OtherExpendituresAmt |
| End Year Balance | $113,515,359 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $94,766,972 | BeginningYearBalanceAmt |
| Contributions | $671,355 | ContributionsAmt |
| Investment Earnings Or Losses | $14,059,961 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $4,513,248 | OtherExpendituresAmt |
| End Year Balance | $104,985,040 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $112,901,289 | BeginningYearBalanceAmt |
| Contributions | $848,275 | ContributionsAmt |
| Investment Earnings Or Losses | -$13,361,785 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $5,620,807 | OtherExpendituresAmt |
| End Year Balance | $94,766,972 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $99,612,019 | BeginningYearBalanceAmt |
| Contributions | $1,371,435 | ContributionsAmt |
| Investment Earnings Or Losses | $16,077,669 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $4,159,834 | OtherExpendituresAmt |
| End Year Balance | $112,901,289 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $89,992,682 | BeginningYearBalanceAmt |
| Contributions | $4,494,881 | ContributionsAmt |
| Investment Earnings Or Losses | $9,457,908 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $4,333,452 | OtherExpendituresAmt |
| End Year Balance | $99,612,019 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Board Designated Balance EOY | 0.98030 | BoardDesignatedBalanceEOYPct |
| Prmnnt Endowment Balance EOY | 0.01970 | PrmnntEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | 0 | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | Yes (1) | EndowmentsHeldRelatedOrgInd |
| Related Org List Sch R | Yes (1) | RelatedOrgListSchRInd |
Land LandGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $4,268,493 | OtherCostOrOtherBasisAmt |
| Book Value | $4,268,493 | BookValueAmt |
Buildings BuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $69,535,581 | OtherCostOrOtherBasisAmt |
| Depreciation | $51,296,417 | DepreciationAmt |
| Book Value | $18,239,164 | BookValueAmt |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $2,652,452 | OtherCostOrOtherBasisAmt |
| Depreciation | $1,008,230 | DepreciationAmt |
| Book Value | $1,644,222 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $49,301,473 | OtherCostOrOtherBasisAmt |
| Depreciation | $36,453,151 | DepreciationAmt |
| Book Value | $12,848,322 | BookValueAmt |
Other Land Buildings OtherLandBuildingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $14,965,166 | OtherCostOrOtherBasisAmt |
| Depreciation | $934,047 | DepreciationAmt |
| Book Value | $14,031,119 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $51,031,320 | TotalBookValueLandBuildingsAmt |
Other Securities OtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | INVESTMENT IN CENETRON | Desc |
| Book Value | $16,217,402 | BookValueAmt |
| Method Valuation | F | MethodValuationCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Securities | $16,217,402 | TotalBookValueSecuritiesAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp (3 entries)
| DescDesc | AmtAmt |
|---|---|
| LONG TERM RETIREMENT LIABILITIES | $10,895,969 |
| LEASE LIABILITY | $3,598,811 |
| ADDITIONAL INCENTIVES | $2,219,970 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $16,714,750 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $281,101,289 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | $999,785 | NetUnrealizedGainsInvstAmt |
| Revenue Not Reported | $999,785 | RevenueNotReportedAmt |
| Revenue Subtotal | $280,101,504 | RevenueSubtotalAmt |
| Investment Expenses Not Incld | $5,895 | InvestmentExpensesNotIncldAmt |
| Other Revenues Not Included | $912,848 | OtherRevenuesNotIncludedAmt |
| Revenue Not Reported Fincl Stmt | $918,743 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $281,020,247 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $264,022,340 | TotExpnsEtcAuditedFinclStmtAmt |
| Other Expenses Included | $387,148 | OtherExpensesIncludedAmt |
| Expenses Not Reported | $387,148 | ExpensesNotReportedAmt |
| Expenses Subtotal | $263,635,192 | ExpensesSubtotalAmt |
| Investment Expenses Not Incld2 | $5,895 | InvestmentExpensesNotIncld2Amt |
| Expenses Not Rpt Fincl Stmt | $5,895 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $263,641,087 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (4 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART V, LINE 4: | ENDOWMENTS THE FILING ORGANIZATION IS A BENEFICIARY OF THE VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION'S ("VBRIF") ENDOWMENT AS A SUPPORTED ORGANIZATION. THE BOARD DESIGNATED ENDOWMENT FUNDS ARE DESIGNATED BY THE BOARD AS ENDOWMENT FUNDS TO ENSURE THE CONTINUING AVAILABILITY OF FUNDS FOR RESEARCH PURPOSES. |
| PART X, LINE 2: | INCOME TAXES VERSITI, WISCONSIN, ILLINOIS, MICHIGAN, INDIANA AND THE FOUNDATION HAVE ALL RECEIVED TAX DETERMINATION LETTERS CONFIRMING THAT THE ORGANIZATIONS QUALIFY AS TAX-EXEMPT ORGANIZATIONS UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (IRC). THE ORGANIZATION FOLLOWS GUIDANCE THAT CLARIFIES THE ACCOUNTING FOR UNCERTAINTY IN TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING ISSUES RELATING TO FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT. THIS GUIDANCE PROVIDES THAT THE TAX EFFECTS FROM AN UNCERTAIN TAX POSITION CAN ONLY BE RECOGNIZED IN THE FINANCIAL STATEMENTS IF THE POSITION IS MORE LIKELY THAN NOT TO BE SUSTAINED IF THE POSITION WERE TO BE CHALLENGED BY A TAXING AUTHORITY. THE ASSESSMENT OF THE TAX POSITION IS BASED SOLELY ON THE TECHNICAL MERITS OF THE POSITION, WITHOUT REGARD TO THE LIKELIHOOD THAT THE TAX POSITION MAY BE CHALLENGED. VERSITI, WISCONSIN, ILLINOIS, MICHIGAN, INDIANA AND THE FOUNDATION ARE EXEMPT FROM FEDERAL INCOME TAX UNDER IRC SECTION 501(C)(3), THOUGH THEY ARE SUBJECT TO TAX ON INCOME UNRELATED TO THEIR EXEMPT PURPOSES, UNLESS THAT INCOME IS OTHERWISE EXCLUDED BY THE IRC. THE ORGANIZATION HAS PROCESSES PRESENTLY IN PLACE TO ENSURE THE MAINTENANCE OF ITS TAX-EXEMPT STATUS; TO IDENTIFY AND REPORT UNRELATED INCOME; TO DETERMINE ITS FILING AND TAX OBLIGATIONS IN JURISDICTIONS FOR WHICH IT HAS NEXUS; AND TO IDENTIFY AND EVALUATE OTHER MATTERS THAT MAY BE CONSIDERED TAX POSITIONS. THE ORGANIZATION FILES FEDERAL AND STATE INCOME TAX RETURNS TO REPORT UNRELATED BUSINESS INCOME WHERE APPLICABLE, AND WITH FEW EXCEPTIONS, THOSE PERIODS GENERALLY REMAIN OPEN THREE YEARS FOR FEDERAL PURPOSES AND FOUR YEARS FOR STATE PURPOSES. THE STATUTE OF LIMITATIONS WILL REMAIN OPEN FOR ANY YEARS WHERE RETURNS WERE NOT FILED. THE ORGANIZATION HAS DETERMINED THAT THERE ARE NO MATERIAL UNCERTAIN TAX POSITIONS THAT REQUIRE RECOGNITION OR DISCLOSURE IN THE CONSOLIDATED FINANCIAL STATEMENTS. SALUS HAS BEEN ORGANIZED AS A LIMITED LIABILITY COMPANY AND, ACCORDINGLY, IS NOT SUBJECT TO FEDERAL OR STATE INCOME TAXES. ALL INCOME TAX ATTRIBUTES OF THE ENTITY ARE PASSED THROUGH TO ITS SOLE MEMBER, WISCONSIN. THE ENTITY IS, HOWEVER, SUBJECT TO TEXAS FRANCHISE TAX. THE ENTITY IS INCLUDED IN THE CONSOLIDATED INFORMATION RETURN FILED BY VERSITI WISCONSIN. CENETRON HAS BEEN ORGANIZED AS A WHOLLY OWNED LLC THAT HAS ELECTED TO BE TREATED AS A C-CORPORATION FOR TAX PURPOSES AND SO IS SUBJECT TO FEDERAL AND STATE INCOME TAXES. INCOME TAXES ARE PROVIDED FOR THE TAX EFFECTS OF TRANSACTIONS REPORTED BY CENETRON AND CONSIST OF TAXES CURRENTLY DUE AND DEFERRED TAXES. DEFERRED TAXES ARE RECOGNIZED FOR DIFFERENCES BETWEEN THE BASIS OF ASSETS AND LIABILITIES FOR FINANCIAL STATEMENT AND INCOME TAX PURPOSES. THE DIFFERENCES RELATE PRIMARILY TO INTANGIBLE ASSETS. THE DEFERRED TAX ASSETS AND LIABILITIES REPRESENT THE FUTURE TAX RETURN CONSEQUENCES OF THOSE DIFFERENCES, WHICH WILL EITHER BE TAXABLE OR DEDUCTIBLE WHEN THE ASSETS AND LIABILITIES ARE RECOVERED OR SETTLED. CENETRON IS SUBJECT TO TAXATION IN THE UNITED STATES AND THE STATE OF TEXAS. QUANTIGEN HAS BEEN ORGANIZED AS A DISREGARDED ENTITY AND, ACCORDINGLY, IS NOT SUBJECT TO FEDERAL OR STATE INCOME TAXES. ALL INCOME TAX ATTRIBUTES OF THE ENTITY ARE PASSED THROUGH TO ITS SOLE MEMBER, WISCONSIN. PEARL PATHWAYS HAS BEEN ORGANIZED AS A DISREGARDED ENTITY AND, ACCORDINGLY, IS NOT SUBJECT TO FEDERAL OR STATE INCOME TAXES. ALL INCOME TAX ATTRIBUTES OF THE ENTITY ARE PASSED THROUGH TO ITS SOLE MEMBER, WISCONSIN. THE CONSOLIDATED DEFERRED TAX LIABILITY WAS $467,474 AND $675,285 AS OF DECEMBER 31, 2024 AND 2023, RESPECTIVELY, AND PRIMARILY RELATES TO INTANGIBLES. THERE WAS DEFERRED INCOME TAX EXPENSE FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023 OF $400,584 AND $371,200, RESPECTIVELY. THE ORGANIZATION RECOGNIZES, IF NECESSARY, INTEREST AND PENALTIES RELATED TO UNRECOGNIZED TAX BENEFITS IN THE PROVISION FOR INCOME TAXES. THERE WERE NO MATERIAL INTEREST OR PENALTIES RELATED TO INCOME TAXES THAT HAVE BEEN ACCRUED OR RECOGNIZED AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023. |
| PART XI, LINE 4B - OTHER ADJUSTMENTS: | CHANGES IN EQUITY IN CENETRON -504,088. GAIN ON DISPOSITION OF FIXED ASSETS 36,770. RENTAL ACTIVITY EXPENSES -12,144. INVESTMENT IN AFFILIATE BALANCE SHEET AMOUNT 1,430,000. FUNDRAISING EXPENSES -37,690. |
| PART XII, LINE 2D - OTHER ADJUSTMENTS: | BAD DEBT RESERVE ADJUSTMENT 374,084. GAIN ON DISPOSITION OF FIXED ASSETS -36,770. RENTAL ACTIVITY EXPENSES 12,144. FUNDRAISING EXPENSES 37,690. |
Schedule G IRS990ScheduleG
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | VERSITI ON KING LUNCH | Event1Nm |
| Gross Receipts Event1 | $91,734 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $65,534 | CharitableContriEvent1Amt |
| Gross Revenue Event1 | $26,200 | GrossRevenueEvent1Amt |
| Food And Beverage Event1 | $13,975 | FoodAndBeverageEvent1Amt |
| Other Direct Expenses Event1 | $23,715 | OtherDirectExpensesEvent1Amt |
| Gross Receipts Total | $91,734 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $65,534 | CharitableContributionsTotAmt |
| Gross Revenue Total Events | $26,200 | GrossRevenueTotalEventsAmt |
| Food And Beverage Total Events | $13,975 | FoodAndBeverageTotalEventsAmt |
| Oth Direct Expnss Total Events | $23,715 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $37,690 | DirectExpenseSummaryEventsAmt |
| Net Income Summary | -$11,490 | NetIncomeSummaryAmt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (4 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Non Cash AssistanceNonCashAssistanceAmt | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|---|
| VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION | ||||||||
| PO BOX 2178 638 N 18TH STREET | MILWAUKEE | WI | 532012178 | 391372542 | 501(C)(3) | $3,810,000 | $0 | RESEARCH |
| GREAT LAKES HEMOPHILIA FOUUNDATION INC | ||||||||
| 638 N 18TH ST | MILWAUKEE | WI | 53233 | 237367636 | 501(C)(3) | $129,750 | $0 | PATIENT FINANCIAL ASSISTANCE |
| MARCUS PERFORMING ARTS CENTER | ||||||||
| 929 N WATER ST | MILWAUKEE | WI | 53202 | 510532407 | 501(C)(3) | $10,000 | $0 | GENERAL SUPPORT |
| WISCONSIN STATE FAIR PARK FOUNDATION | ||||||||
| 640 S 84TH ST | WEST ALLIS | WI | 53214 | 391840248 | 501(C)(3) | $7,000 | $0 | GENERAL SUPPORT |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 4 | Total501c3OrgCnt |
Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Type | SCHOLARSHIPS | GrantTypeTxt |
| Recipient | 1 | RecipientCnt |
| Cash Grant | $4,000 | CashGrantAmt |
| Valuation Method Used | FMV | ValuationMethodUsedDesc |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | PROCEDURE FOR MONITORING USE OF GRANT FUNDS INSIDE U.S. VERSITI WISCONSIN CONTINUES TO PROVIDE GRANT FUNDING TO VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION, INC. AND OTHER TAX-EXEMPT ORGANIZATIONS. THESE FUNDS WILL SUPPORT FUTURE BLOOD RESEARCH AND OTHER INITIATIVES TO SERVE MORE PATIENTS AND REDUCE OVERALL COSTS. MONITORING THE INVESTMENT OF THESE FUNDS, THE DISTRIBUTIONS AND WHAT THESE FUNDS ARE USED FOR IS COMPLETED BY LEADERSHIP OF VERSITI WISCONSIN. ADDITIONALLY, THE FILING ORGANIZATION OFFERS SCHOLARSHIPS TO EMPLOYEES AND COMMUNITY MEMBERS IF CERTAIN CRITERIA ARE MET. THE SCHOLARSHIPS ARE SENT TO THE COLLEGE OR UNIVERSITY WHERE THE STUDENT IS ENROLLED. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | Yes (1) | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | Yes (1) | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | Yes (1) | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | Yes (1) | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | Yes (1) | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (19 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CHRIS MISKEL | ||||||||||||||
| PRESIDENT & CEO | $350,722 | $446,376 | $352,309 | $448,395 | $10,909 | $13,885 | $10,626 | $13,525 | $14,748 | $18,770 | $739,314 | $940,951 | $0 | $0 |
| BART REUTER | ||||||||||||||
| EVP & GENERAL COUNSEL | $189,439 | $241,106 | $178,380 | $227,030 | $11,283 | $14,362 | $10,626 | $13,525 | $18,433 | $23,462 | $408,161 | $519,485 | $0 | $0 |
| BRIAN BAUTISTA | ||||||||||||||
| EVP & CHIEF OPERATING OFFICER | $204,932 | $260,825 | $143,060 | $182,076 | $9,623 | $12,249 | $8,081 | $10,285 | $15,499 | $19,727 | $381,195 | $485,162 | $0 | $0 |
| ANTHONY WATKINS | ||||||||||||||
| EVP&CFO-THRU 3/24;BUS DEV-AS OF 3/24 | $144,004 | $183,278 | $155,980 | $198,520 | $29,449 | $37,480 | $10,626 | $13,525 | $2,518 | $3,207 | $342,577 | $436,010 | $0 | $0 |
| MICHAEL DEININGER MD | ||||||||||||||
| EVP & CHIEF SCIENTIFIC OFFICER | $497,386 | $26,178 | $112,195 | $5,905 | $27,499 | $1,447 | $15,090 | $794 | $22,180 | $1,167 | $674,350 | $35,491 | $0 | $0 |
| BRADLEY PIETZ | ||||||||||||||
| EVP & CHIEF LABORATORY OFFICER | $135,259 | $172,151 | $117,801 | $149,929 | $11,340 | $14,435 | $10,538 | $13,413 | $18,251 | $23,228 | $293,189 | $373,156 | $0 | $0 |
| JAMES WEIDNER | ||||||||||||||
| EVP & CHIEF HR OFFICER | $140,199 | $178,436 | $100,156 | $127,471 | $11,149 | $14,191 | $10,626 | $13,525 | $14,361 | $18,280 | $276,491 | $351,903 | $0 | $0 |
| MATTHEW ANDERSON MD | ||||||||||||||
| EVP & CHIEF MED. OFF. - AS OF 7/24 | $403,926 | $0 | $65,100 | $0 | $2,842 | $0 | $24,150 | $0 | $41,700 | $0 | $537,718 | $0 | $0 | $0 |
| LYNNE BRIGGS | ||||||||||||||
| VP & CHIEF INFORMATION OFFICER | $141,179 | $179,684 | $67,763 | $86,243 | $3,078 | $3,919 | $11,595 | $14,758 | $11,558 | $14,711 | $235,173 | $299,315 | $0 | $0 |
| DEREK TYUS | ||||||||||||||
| EVP & CHIEF FINANCIAL OFF. - AS 3/24 | $144,868 | $184,379 | $52,800 | $67,200 | $1,345 | $1,712 | $10,425 | $13,268 | $10,851 | $13,809 | $220,289 | $280,368 | $0 | $0 |
| KATHLEEN PUCA | ||||||||||||||
| SR MEDICAL DIRECTOR | $345,435 | $0 | $67,100 | $0 | $30,022 | $0 | $27,600 | $0 | $27,900 | $0 | $498,057 | $0 | $0 | $0 |
| BARBARA BRYANT | ||||||||||||||
| EVP & CHIEF MED. OFF. - THRU 8/24 | $328,620 | $0 | $101,700 | $0 | $17,502 | $0 | $23,946 | $0 | $1,902 | $0 | $473,670 | $0 | $0 | $0 |
| CHRISTIAN J KASTRUP PHD | ||||||||||||||
| SR INVESTIGATOR | $377,833 | $0 | $19,900 | $0 | $1,486 | $0 | $20,250 | $0 | $41,632 | $0 | $461,101 | $0 | $0 | $0 |
| KARIN HOFFMEISTER | ||||||||||||||
| DEPUTY DIRECTOR VBRI | $353,991 | $0 | $41,800 | $0 | $15,255 | $0 | $14,309 | $0 | $35,019 | $0 | $460,374 | $0 | $0 | $0 |
| LISA BAUMANN KREUZIGER | ||||||||||||||
| SENIOR MEDICAL DIRECTOR | $345,859 | $0 | $23,800 | $0 | $25,277 | $0 | $24,150 | $0 | $16,428 | $0 | $435,514 | $0 | $0 | $0 |
| GITESH DUBAL | ||||||||||||||
| EVP & CHIEF MKTG. OFF. - THRU 4/24 | $56,655 | $72,103 | $113,676 | $144,678 | $8,777 | $11,171 | $4,651 | $5,920 | $5,813 | $7,397 | $189,572 | $241,269 | $0 | $0 |
| LYNN M MALEC MD | ||||||||||||||
| SENIOR MEDICAL DIRECTOR | $361,479 | $0 | $18,100 | $0 | $4,668 | $0 | $17,926 | $0 | $16,964 | $0 | $419,137 | $0 | $0 | $0 |
| JESSICA DROUILLARD | ||||||||||||||
| VP & CHIEF QUALITY OFFICER | $86,807 | $110,482 | $24,376 | $31,024 | $10,272 | $13,076 | $6,776 | $8,624 | $1,543 | $1,962 | $129,774 | $165,168 | $0 | $0 |
| GRETCHEN JAMESON | ||||||||||||||
| EVP & CHIEF MKTG. OFF. - AS OF 4/24 | $96,463 | $122,769 | $0 | $0 | $520 | $663 | $6,042 | $7,689 | $563 | $719 | $103,588 | $131,840 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| PART I, LINE 3 | TOP MANAGEMENT'S COMPENSATION THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS, ACTING IN ITS CAPACITY AS THE COMPENSATION COMMITTEE, SETS AND MONITORS THE COMPENSATION PHILOSOPHY FOR THE FILING ORGANIZATION. OTHER THAN THE VERSITI PRESIDENT AND CHIEF EXECUTIVE OFFICER, THE EXECUTIVE COMMITTEE DOES NOT INCLUDE MEMBERS OF MANAGEMENT. TO ENSURE THAT THE COMMITTEE IS COMPRISED OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITH RESPECT TO VERSITI COMPENSATION ARRANGEMENTS, THE VERSITI PRESIDENT AND CHIEF EXECUTIVE OFFICER RECUSES HER/HIMSELF FROM ALL DISCUSSIONS AND APPROVALS RELATED TO HER/HIS COMPENSATION. THE EXECUTIVE COMMITTEE REVIEWS EXECUTIVE COMPENSATION ARRANGEMENTS TO ENSURE SUCH ARRANGEMENTS ARE FAIR, REASONABLE, AND NOT EXCESSIVE WHEN COMPARED TO SIMILARLY-SITUATED EXECUTIVES. EXECUTIVE COMPENSATION ARRANGEMENTS ARE REVIEWED FOR REASONABLENESS AND APPROVED BY THE EXECUTIVE COMMITTEE ANNUALLY IN ACCORDANCE WITH THE VERSITI REASONABLENESS REVIEW POLICY. IN ORDER TO ASSESS THE REASONABLENESS OF EXECUTIVE COMPENSATION ARRANGEMENTS, THE EXECUTIVE COMMITTEE OBTAINS AND REVIEWS APPROPRIATE COMPARABILITY DATA COLLECTED BY THE HUMAN RESOURCE DEPARTMENT AND/OR A QUALIFIED INDEPENDENT COMPENSATION CONSULTANT. THE EXECUTIVE COMMITTEE ENGAGES A QUALIFIED INDEPENDENT COMPENSATION CONSULTANT ANNUALLY. THE INDEPENDENT CONSULTANT PERFORMS AN ANALYSIS OF COMPENSATION LEVELS AT REGIONAL AND NATIONAL ORGANIZATIONS OF COMPARABLE SIZE, SCOPE AND STRUCTURE; AND PROVIDES THE COMMITTEE WITH COMPREHENSIVE DATA ON THE AVAILABILITY OF SIMILAR SERVICES WITHIN THE GEOGRAPHIC AREA, COMPENSATION SURVEYS, WRITTEN OFFERS FROM SIMILAR INSTITUTIONS, AND OTHER INFORMATION RELEVANT TO COMPARABILITY OF COMPENSATION. THE EXECUTIVE COMMITTEE'S REVIEW, RECOMMENDATIONS AND APPROVALS ARE DOCUMENTED CONCURRENTLY IN THE COMMITTEE MINUTES, WHICH ARE SUBSEQUENTLY REVIEWED AND APPROVED BY THE EXECUTIVE COMMITTEE AS REASONABLE, ACCURATE AND COMPLETE. THE COMMITTEE CHAIR VERBALLY COMMUNICATES TO THE BOARD OF DIRECTORS A CONFIRMATION OF COMPENSATION REASONABLENESS AND THE OVERALL DUE DILIGENCE PROCESS. VERSITI WISCONSIN HAS INCENTIVE PROGRAMS FOR EXECUTIVES, DIRECTORS, MANAGEMENT, INVESTIGATORS AND STAFF DESCRIBED IN DETAILED WRITTEN POLICIES APPROVED BY THE EXECUTIVE COMMITTEE ANNUALLY. EVALUATION AND COMPENSATION REVIEW -CEO - EACH YEAR, THE EXECUTIVE COMMITTEE EVALUATES THE CEO'S PERFORMANCE AGAINST ESTABLISHED OBJECTIVES, DETERMINES INCENTIVE PAYMENT AND MERIT INCREASE BASED UPON PERFORMANCE AND MARKET DATA PROVIDED BY THE THIRD PARTY COMPENSATION CONSULTANT, AND WORKS WITH THE CEO TO ESTABLISH OBJECTIVES FOR THE NEXT YEAR. -EXECUTIVES - THE BOARD OF DIRECTORS HAS DELAGATED TO THE CEO THE PERFORMANCE ASSESSMENT AND COMPENSATION DECISIONS FOR HIS/HER TEAM AND LEADERS ELIGIBLE FOR THE VERSITI LEADERSHIP INCENTIVE PLAN. DURING THE MAY MEETING, THE EXECUTIVE COMMITTEE REVIEWS THE INCENTIVES (SHORT AND LONG-TERM) PAYOUTS AND MERIT INCREASES ASSIGNED TO THE EXECUTIVE TEAM AS PART OF THE ANNUAL COMPENSATION REASONABILITY REVIEW CONDUCTED BY AON CONSULTANTS. THE EXECUTIVE COMMITTEE REVIEWS AND APPROVES THE SALARY INCREASES AND INCENTIVE PAYOUTS OF THE CEO BEFORE PAYMENT. EXECUTIVES ARE POSITIONED WITHIN THE APPROPRIATE SALARY RANGE BASED UPON THE: -EXECUTIVE'S KNOWLEDGE, COMPETENCIES, AND EXPERIENCE, -PERFORMANCE OF THE EXECUTIVE'S AREAS OF RESPONSIBILITY, -THE EXECUTIVE'S CONTRIBUTION TO OVERALL PERFORMANCE, -THE IMPORTANCE OF RETAINING THE EXECUTIVE, -INTERNAL EQUITY CONSIDERATIONS, -THE FINANCIAL RESOURCES AVAILABLE, AND -EXECUTIVE BASE SALARY INCREASES PROVIDED IN THE COMPETITIVE MARKET. |
| PART I, LINE 5A, 5B, 6A, 6B AND 7: | NON-FIXED PAYMENTS INCENTIVE PAYOUT OPPORTUNITIES, BASED ON PERCENTAGE OF BASE PAY RATE, ARE AVAILABLE TO CERTAIN EMPLOYEES OF THE FILING ORGANIZATION. WHILE LEVELS OF THE INCENTIVE PAYOUT OPPORTUNITY ARE FIXED AND DETERMINED PERCENTAGES OF BASE COMPENSATION, THE INCENTIVE PAYOUT IS DETERMINED, IN PART, ON THE CONSOLIDATED REVENUE AND NET EARNINGS OF OPERATING DIVISIONS. THE INCENTIVE PAYOUT IS SUBJECT TO THE REVIEW OF ACCOMPLISHMENTS/OBJECTIVES AND THE ULTIMATE DETERMINATION OF INCENTIVE COMPENSATION IS SUBJECT TO PRESIDENT/CEO AND EXECUTIVE COMMITTEE OF THE BOARD APPROVAL. |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (11 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART I, LINE 1 | VERSITI WISCONSIN, INC. (VERSITI WISCONSIN) IS A BLOOD HEALTH INNOVATOR WHICH ENHANCES LIVES THROUGH DISCOVERY, DIAGNOSIS AND TREATMENT. VERSITI EXPANDS THE FRONTIERS OF PATIENT HEALTH THROUGH THE INTEGRATION OF SCIENCE, MEDICINE AND SERVICE. |
| FORM 990, PART VI, SECTION A, LINE 6 | MEMBERS OR STOCKHOLDERS VERSITI, INC. IS THE SOLE CORPORATE MEMBER. |
| FORM 990, PART VI, SECTION A, LINE 7A | MEMBER OR STOCKHOLDER POWERS VERSITI, INC. HAS RESERVE POWERS; INCLUDING THE ABILITY TO ELECT A MAJORITY OF DIRECTORS. |
| FORM 990, PART VI, SECTION A, LINE 7B | REFER TO NARRATIVE LISTED IN LINE 7A. |
| FORM 990, PART VI, SECTION B, LINE 11B | FORM 990 REVIEW VERSITI WISCONSIN UTILIZES GRANT THORNTON TO COMPLETE THE IRS FORM 990 AND RELATED SCHEDULES. FOLLOWING COMPLETION, THEY ARE REVIEWED BY THE ORGANIZATION'S MANAGEMENT. THE DRAFT FORMS ARE THEN REVIEWED BY THE AUDIT AND COMPLIANCE COMMITTEE PRIOR TO SUBMISSION TO THE IRS. THE FULL BOARD IS PROVIDED A COPY OF THE FORM 990 PRIOR TO FILING. |
| FORM 990, PART VI, SECTION B, LINE 12C | CONFLICT OF INTEREST POLICY VERSITI WISCONSIN MAINTAINS A WRITTEN CONFLICT OF INTEREST POLICY. ON AN ANNUAL BASIS, CURRENT DIRECTORS AND OFFICERS ARE ASKED TO COMPLETE A DISCLOSURE FORM BASED ON IRS REQUIREMENTS THAT INCLUDES THE FOLLOWING: WHETHER THEY HAVE ANY DIRECT OR INDIRECT RELATIONSHIP EITHER THROUGH BUSINESS OR FAMILY MEMBER WITH THE ORGANIZATION. WHETHER THEY RECEIVED COMPENSATION FROM ANY ORGANIZATION THAT SHARES COMMON OWNERSHIP OR CONTROL WITH THE ORGANIZATION. WHETHER THEY HAVE SERVED AS AN OFFICER, DIRECTOR, KEY EMPLOYEE, PARTNER OR MEMBER OF AN ENTITY (OR SHAREHOLDER OF A PROFESSIONAL CORPORATION) DOING BUSINESS WITH THE ORGANIZATION. THESE ANSWERS ARE ACCUMULATED, SUMMARIZED AND EVALUATED BY MANAGEMENT TO DETERMINE IF ANY CONFLICTS EXIST. IDENTIFIED CONFLICTS ARE ADDRESSED IN ACCORDANCE WITH THE WRITTEN POLICY. |
| FORM 990, PART VI, SECTION B, LINE 15 | COMPENSATION PROCESS THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS, ACTING IN ITS CAPACITY AS THE COMPENSATION COMMITTEE, SETS AND MONITORS THE COMPENSATION PHILOSOPHY FOR THE FILING ORGANIZATION. |
| FORM 990, PART VI, SECTION C, LINE 19 | ORGANIZATION'S DOCUMENTS OPEN TO THE PUBLIC THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE UPON REQUEST TO THE PUBLIC DURING NORMAL BUSINESS HOURS AND AT THE ORGANIZATION'S LOCATION. |
| PART VII: | AVERAGE HOURS THE HOURS LISTED ON FORM 990, PART VII ARE REPRESENTATIVE OF AN AVERAGE FOR THE OFFICERS AND EXECUTIVE TEAM. EACH INDIVIDUAL PERSON'S WEEKLY TALLY MAY BE GREATER OR LESSER PER WEEK BASED ON THEIR INDIVIDUAL ROLES AND RESPONSIBILITIES WITHIN THE FILING ORGANIZATION AND RELATED PARTIES. |
| FORM 990, PART IX, LINE 11G | SHIPPING & TRANSPORTATION: PROGRAM SERVICE EXPENSES 1,892,601. MANAGEMENT AND GENERAL EXPENSES 164,068. TOTAL EXPENSES 2,056,669. OUTSIDE LAB SERVICE: PROGRAM SERVICE EXPENSES 547,086. TOTAL EXPENSES 547,086. TEMPORARY HELP: PROGRAM SERVICE EXPENSES 445,420. MANAGEMENT AND GENERAL EXPENSES -40,335. TOTAL EXPENSES 405,085. SUBAWARDS: PROGRAM SERVICE EXPENSES 5,782,955. TOTAL EXPENSES 5,782,955. DONOR TESTING: PROGRAM SERVICE EXPENSES 5,744,886. TOTAL EXPENSES 5,744,886. PURCHASED SERVICES: PROGRAM SERVICE EXPENSES 1,255,534. MANAGEMENT AND GENERAL EXPENSES 495,400. TOTAL EXPENSES 1,750,934. ANIMAL CARE COSTS: PROGRAM SERVICE EXPENSES 1,331,489. TOTAL EXPENSES 1,331,489. CONSULTING SERVICES: PROGRAM SERVICE EXPENSES 1,353,566. MANAGEMENT AND GENERAL EXPENSES 56,399. TOTAL EXPENSES 1,409,965. OPERATING ROOM: PROGRAM SERVICE EXPENSES 1,163,168. TOTAL EXPENSES 1,163,168. IRB CONTRACTOR FEES: PROGRAM SERVICE EXPENSES 866,757. TOTAL EXPENSES 866,757. LAB: PROGRAM SERVICE EXPENSES 617,231. TOTAL EXPENSES 617,231. ICU: PROGRAM SERVICE EXPENSES 587,028. TOTAL EXPENSES 587,028. TRANSLATION SERVICE: PROGRAM SERVICE EXPENSES 491,172. TOTAL EXPENSES 491,172. PHARMACY: PROGRAM SERVICE EXPENSES 478,584. TOTAL EXPENSES 478,584. OTHER HOSPITAL CHARGES: PROGRAM SERVICE EXPENSES 386,278. TOTAL EXPENSES 386,278. GRADUATE STUDENT STIPENDS: PROGRAM SERVICE EXPENSES 363,637. TOTAL EXPENSES 363,637. RADIOLOGY: PROGRAM SERVICE EXPENSES 353,846. TOTAL EXPENSES 353,846. CLAIM/BILLING REVIEW: PROGRAM SERVICE EXPENSES 343,423. TOTAL EXPENSES 343,423. OUTSIDE MEDICAL DIRECTOR (OPO): PROGRAM SERVICE EXPENSES 338,895. TOTAL EXPENSES 338,895. CARDIOLOGY: PROGRAM SERVICE EXPENSES 309,386. TOTAL EXPENSES 309,386. FACILITY CHARGES: PROGRAM SERVICE EXPENSES 249,890. TOTAL EXPENSES 249,890. RESPIRATORY THERAPY: PROGRAM SERVICE EXPENSES 203,332. TOTAL EXPENSES 203,332. RECORD STORAGE: PROGRAM SERVICE EXPENSES 8,645. MANAGEMENT AND GENERAL EXPENSES 193,876. TOTAL EXPENSES 202,521. PHYSICIAN FEES: PROGRAM SERVICE EXPENSES 177,046. TOTAL EXPENSES 177,046. ANESTHESIA: PROGRAM SERVICE EXPENSES 159,955. TOTAL EXPENSES 159,955. LICENSES, PERMITS, & HOSP FEES: PROGRAM SERVICE EXPENSES 109,085. MANAGEMENT AND GENERAL EXPENSES 5,733. TOTAL EXPENSES 114,818. EDUCATION: PROGRAM SERVICE EXPENSES 73,611. MANAGEMENT AND GENERAL EXPENSES 33,663. TOTAL EXPENSES 107,274. DNA SEQUENCING: PROGRAM SERVICE EXPENSES 91,053. TOTAL EXPENSES 91,053. FUNERAL HOME CHARGES: PROGRAM SERVICE EXPENSES 85,305. TOTAL EXPENSES 85,305. PS SUPPLIES: PROGRAM SERVICE EXPENSES 84,572. TOTAL EXPENSES 84,572. CUSTOMER TESTING: PROGRAM SERVICE EXPENSES 54,813. TOTAL EXPENSES 54,813. PUBLICATION SERVICES: PROGRAM SERVICE EXPENSES 49,888. MANAGEMENT AND GENERAL EXPENSES 3,018. TOTAL EXPENSES 52,906. NON-MARKETING PRINTING COSTS : PROGRAM SERVICE EXPENSES 29,435. MANAGEMENT AND GENERAL EXPENSES 3,967. TOTAL EXPENSES 33,402. OUTSIDE CORE LAB CHARGES: PROGRAM SERVICE EXPENSES 25,836. TOTAL EXPENSES 25,836. OTHER PURCHASE SERV AFFILIATES: PROGRAM SERVICE EXPENSES 16,541. TOTAL EXPENSES 16,541. NON-HOSPITAL BUSINESS DEVELOPMENT: PROGRAM SERVICE EXPENSES 14,538. TOTAL EXPENSES 14,538. PHARMACY DISPENSING FEE: PROGRAM SERVICE EXPENSES 12,635. TOTAL EXPENSES 12,635. BANK ACCOUNT FEES: PROGRAM SERVICE EXPENSES 9,223. MANAGEMENT AND GENERAL EXPENSES 1,816. TOTAL EXPENSES 11,039. LAUNDRY COSTS: PROGRAM SERVICE EXPENSES 8,846. TOTAL EXPENSES 8,846. VARIABLE LEASES PRINTING SERVICES: MANAGEMENT AND GENERAL EXPENSES 588. TOTAL EXPENSES 588. MEDICAL REPORTS: PROGRAM SERVICE EXPENSES 79. TOTAL EXPENSES 79. EMPLOYMENT RECRUITMENT FEES: PROGRAM SERVICE EXPENSES 20. TOTAL EXPENSES 20. |
| FORM 990, PART XI, LINE 9: | BAD DEBT RESERVE ADJUSTMENT -374,084. CHANGE IN EQUITY IN CENETRON 504,088. INVESTMENT IN AFFILIATE BALANCE SHEET AMOUNT -1,430,000. |
Schedule R IRS990ScheduleR
Id Disregarded Entities IdDisregardedEntitiesGrp (3 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Total IncomeTotalIncomeAmt | End Of Year AssetsEndOfYearAssetsAmt | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt |
|---|---|---|---|---|---|---|---|---|---|
| RCRC INDEPENDENT REVIEW BOARD LLC | |||||||||
| 2111 W BRAKER LANE SUITE 100 | AUSTIN | TX | 78758 | 390807235 | REVIEW BOARD | TX | $5,691,154 | $4,567,553 | VERSITI WI |
| QUANTIGEN LLC | |||||||||
| 10300 KINCAID DR STE 200 | FISHERS | IN | 46037 | 260229477 | SPECIALTY LAB SERVICES | IN | $8,575,322 | $22,717,169 | VERSITI WI |
| PEARL IRB LLC | |||||||||
| 29 E MCCARTY ST STE 100 | INDIANAPOLIS | IN | 46225 | 271927520 | REGULATORY AFFAIRS CONSULTING SERVICES | IN | $3,994,527 | $11,401,801 | VERSITI WI |
Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (5 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | EINEIN | Primary ActivitiesPrimaryActivitiesTxt | Legal Domicile StateLegalDomicileStateCd | Exempt Code SectionExemptCodeSectionTxt | Public Charity StatusPublicCharityStatusTxt | Business Name Line1DirectControllingEntityName/BusinessNameLine1Txt | Controlled OrganizationControlledOrganizationInd | Direct Controlling NADirectControllingNACd |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VERSITI BLOOD RESEARCH INSTITUTE FNDN | |||||||||||
| PO BOX 2178 638 N 18TH ST | MILWAUKEE | WI | 53201 | 391372542 | SUPPORTING | WI | 501(C)(3) | LINE 12B, II | VERSITI | 0 | |
| VERSITI INC | |||||||||||
| PO BOX 2178 638 N 18TH ST | MILWAUKEE | WI | 53201 | 454675354 | SUPPORTING | WI | 501(C)(3) | LINE 12B, II | 0 | N/A | |
| VERSITI ILLINOIS INC | |||||||||||
| 1200 N HIGHLAND AVE | AURORA | IL | 60506 | 362179768 | BLOOD | IL | 501(C)(3) | LINE 10 | VERSITI | 0 | |
| VERSITI MICHIGAN INC | |||||||||||
| 1036 FULLER AVE NE | GRAND RAPIDS | MI | 49503 | 381550001 | BLOOD | MI | 501(C)(3) | LINE 10 | VERSITI | 0 | |
| VERSITI INDIANA INC | |||||||||||
| 3450 N MERIDIAN ST | INDIANAPOLIS | IN | 46208 | 350991629 | BLOOD | IN | 501(C)(3) | LINE 10 | VERSITI | 0 | |
Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp
Related Organization Name RelatedOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CENETRON DIAGNOSTICS LLC | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 2111 W BRAKER LANE SUITE 300 | AddressLine1Txt |
| City | AUSTIN | CityNm |
| State Abbreviation | TX | StateAbbreviationCd |
| ZIP | 78758 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 742760677 | EIN |
| Primary Activities | LABS & TRIALS | PrimaryActivitiesTxt |
| Legal Domicile State | TX | LegalDomicileStateCd |
Direct Controlling Entity Name DirectControllingEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | VERSITI WI | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Entity Type | C | EntityTypeTxt |
| Share Of Total Income | $504,088 | ShareOfTotalIncomeAmt |
| Share Of EOY Assets | $20,800,182 | ShareOfEOYAssetsAmt |
| Ownership | 1.00000 | OwnershipPct |
| Controlled Organization | Yes (1) | ControlledOrganizationInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | 0 | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | Yes (1) | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | Yes (1) | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | 0 | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | 0 | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | Yes (1) | DivRelatedOrganizationInd |
| Asset Sale To Other Org | Yes (1) | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | Yes (1) | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | 0 | AssetExchangeInd |
| Rental Of Facilities To Oth Org | 0 | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | Yes (1) | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | Yes (1) | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | Yes (1) | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | Yes (1) | SharingOfFacilitiesInd |
| Paid Employees Sharing | Yes (1) | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | Yes (1) | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | Yes (1) | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | 0 | TransferToOtherOrgInd |
| Transfer From Other Org | 0 | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp (6 entries)
| Transaction TypeTransactionTypeTxt | InvolvedInvolvedAmt | Method Of Amount DeterminationMethodOfAmountDeterminationTxt |
|---|---|---|
| CENETRON DIAGNOSTICS LLC | ||
| F | $1,430,000 | FMV |
| CENETRON DIAGNOSTICS LLC | ||
| K | $194,293 | FMV |
| CENETRON DIAGNOSTICS LLC | ||
| L | $27,260 | FMV |
| CENETRON DIAGNOSTICS LLC | ||
| M | $209,428 | FMV |
| CENETRON DIAGNOSTICS LLC | ||
| P | $196,806 | FMV |
| CENETRON DIAGNOSTICS LLC | ||
| Q | $351,288 | FMV |